ETGLX (ETGLX) Stock Price & Analysis
ETGLX (ETGLX) fell 1.48% to USD 61.43 as of July 26, 2026 at 00:25 UTC, according to Nexqual real-time market data.
ETGLX last closed at USD 62.35; the session ranged USD 61.43–61.43 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 48.82–67.01 (NAS). Source: Nexqual, July 26, 2026 at 00:25 UTC.
Key Statistics (as of July 26, 2026 at 00:25 UTC)
| Price | USD 61.43 |
|---|---|
| Change | ▼ 1.48% (down) |
| Previous Close | USD 62.35 |
| Open | USD 61.43 |
| Day Range | USD 61.43 – 61.43 |
| 52-Week Range | USD 48.82 – 67.01 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (ETGLX)
Nexqual's technical model rates ETGLX "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 00:25 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.3 (neutral) |
| vs SMA50 | Below (USD 62.62) |
| MACD | -0.13 (negative) |
Financial Health Score (ETGLX)
Nexqual rates ETGLX's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 00:25 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ETNHX | Eventide Healthcare & Life Scie | USD 54.17 | ▼ 0.51% |
| ETILX | Eventide Gilead Fund Institutio | USD 64.13 | ▼ 2.11% |
| GTLLX | Glenmede Large Cap Growth Ptf | USD 32.48 | ▼ 0.7% |
| BUFOX | Buffalo Early Stage Growth Fund | USD 18.15 | ▼ 2.21% |
| PARWX | Parnassus Endeavor Fund - Inves | USD 63.77 | ▼ 0.22% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 00:25 UTC. This page is informational and not investment advice.